213 related articles for article (PubMed ID: 27228307)
21. Treatment of Parkinson disease with C17.2 neural stem cells overexpressing NURR1 with a recombined republic-deficit adenovirus containing the NURR1 gene.
Li QJ; Tang YM; Liu J; Zhou DY; Li XP; Xiao SH; Jian DX; Xing YG
Synapse; 2007 Dec; 61(12):971-7. PubMed ID: 17879263
[TBL] [Abstract][Full Text] [Related]
22. Genkwalathins A and B, new lathyrane-type diterpenes from Daphne genkwa.
Van Minh N; Han BS; Choi HY; Byun J; Park JS; Kim WG
Nat Prod Res; 2018 Aug; 32(15):1782-1790. PubMed ID: 29156984
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons.
Grothe C; Timmer M; Scholz T; Winkler C; Nikkhah G; Claus P; Itoh N; Arenas E
Neurobiol Dis; 2004 Nov; 17(2):163-70. PubMed ID: 15474354
[TBL] [Abstract][Full Text] [Related]
24. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
25. Regenerative effects of peptide nanofibers in an experimental model of Parkinson's disease.
Sever M; Turkyilmaz M; Sevinc C; Cakir A; Ocalan B; Cansev M; Guler MO; Tekinay AB
Acta Biomater; 2016 Dec; 46():79-90. PubMed ID: 27619838
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
Ganser C; Papazoglou A; Just L; Nikkhah G
Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
[TBL] [Abstract][Full Text] [Related]
27. Nurr1 overexpression exerts neuroprotective and anti-inflammatory roles via down-regulating CCL2 expression in both in vivo and in vitro Parkinson's disease models.
Liu W; Gao Y; Chang N
Biochem Biophys Res Commun; 2017 Jan; 482(4):1312-1319. PubMed ID: 27940361
[TBL] [Abstract][Full Text] [Related]
28. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
29. Ultrasound-triggered effects of the microbubbles coupled to GDNF- and Nurr1-loaded PEGylated liposomes in a rat model of Parkinson's disease.
Yue P; Gao L; Wang X; Ding X; Teng J
J Cell Biochem; 2018 Jun; 119(6):4581-4591. PubMed ID: 29240240
[TBL] [Abstract][Full Text] [Related]
30. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
Kim HD; Jeong KH; Jung UJ; Kim SR
J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
[TBL] [Abstract][Full Text] [Related]
31. Relationship between sensorimotor gating deficits and dopaminergic neuroanatomy in Nurr1-deficient mice.
Vuillermot S; Feldon J; Meyer U
Exp Neurol; 2011 Nov; 232(1):22-32. PubMed ID: 21820432
[TBL] [Abstract][Full Text] [Related]
32. Transplantation of neural stem cells co-transfected with Nurr1 and Brn4 for treatment of Parkinsonian rats.
Tan X; Zhang L; Qin J; Tian M; Zhu H; Dong C; Zhao H; Jin G
Int J Dev Neurosci; 2013 Feb; 31(1):82-7. PubMed ID: 23085081
[TBL] [Abstract][Full Text] [Related]
33. A new highly oxygenated daphnane diterpene esters from the flower buds of Daphne genkwa.
Jiang HL; Wang R; Li JY; Shi YP
Nat Prod Res; 2015; 29(20):1878-83. PubMed ID: 25674674
[TBL] [Abstract][Full Text] [Related]
34. Effect of Bushen Huoxue Decoction on the orphan receptor and tyrosine hydroxylase in the brain of rats with Parkinson's disease.
Yang MH; Wang HM; Liu Y
Chin J Integr Med; 2011 Jan; 17(1):43-7. PubMed ID: 21258896
[TBL] [Abstract][Full Text] [Related]
35. Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease.
Kumari R; Kumar JB; Luthra PM
Neurosci Lett; 2015 Mar; 589():191-5. PubMed ID: 25528406
[TBL] [Abstract][Full Text] [Related]
36. Melanogenesis inhibitory daphnane diterpenoids from the flower buds of Daphne genkwa.
Bang KK; Yun CY; Lee C; Jin Q; Lee JW; Jung SH; Lee D; Lee MK; Hong JT; Kim Y; Hwang BY
Bioorg Med Chem Lett; 2013 Jun; 23(11):3334-7. PubMed ID: 23623417
[TBL] [Abstract][Full Text] [Related]
37. Neogenkwanine I from the flower buds of
Hou XW; Han S; Zhang YY; Su HB; Gao PY; Li LZ; Song SJ
Nat Prod Res; 2020 Feb; 34(3):405-412. PubMed ID: 30406671
[TBL] [Abstract][Full Text] [Related]
38. Daphnane-type diterpenes with inhibitory activities against human cancer cell lines from Daphne genkwa.
Li F; Sun Q; Hong L; Li L; Wu Y; Xia M; Ikejima T; Peng Y; Song S
Bioorg Med Chem Lett; 2013 May; 23(9):2500-4. PubMed ID: 23558238
[TBL] [Abstract][Full Text] [Related]
39. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease.
Zhu G; Wang X; Chen Y; Yang S; Cheng H; Wang N; Li Q
Planta Med; 2010 Nov; 76(16):1820-6. PubMed ID: 20509103
[TBL] [Abstract][Full Text] [Related]
40. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I
Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
